✦ LIBER ✦

New therapeutic options for invasive fungal diseases

✍ Scribed by Carina A Rodriguez; Christian C Patrick

Book ID: 117833204
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 79 KB
Volume: 12
Category: Article
ISSN: 1045-1870
DOI: 10.1053/spid.2001.26638

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Caspofungin: a new therapeutic option fo

Caspofungin: a new therapeutic option for fungal endocarditis

✍ J. Nevado; A. De Alarcón; A. Hernández 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

New options for the treatment of invasiv

New options for the treatment of invasive fungal infections

✍ Zachary A Rubin; Jyoti Somani 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Treatment Options for Invasive Fungal In

Treatment Options for Invasive Fungal Infections

✍ Elizabeth S. Dodds Ashley 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Therapeutic options for neuromuscular di

Therapeutic options for neuromuscular diseases

✍ Marc Kent 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Overview of treatment options for invasi

Overview of treatment options for invasive fungal infections

✍ Pound, Melanie W.; Townsend, Mary L.; Dimondi, Vincent; Wilson, Dustin; Drew, Ri 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 246 KB

New insights into therapeutic options fo

New insights into therapeutic options for Pompe disease

✍ Emmanuel Richard; Gaëlle Douillard-Guilloux; Catherine Caillaud 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract Glycogen storage disease type II or Pompe disease (GSD II, MIM 232300) is a rare inherited metabolic myopathy caused by a deficiency of lysosomal acid α‐glucosidase or acid maltase (GAA; EC 3.2.1.20), resulting in a massive lysosomal glycogen accumulation in cardiac and skeletal muscles